HIV, cholesterol-lowering and cancer medicines dominate price disclosure reductions for April 2020 with almost thirty medicines across over 60 dosages and manners of administration taking an average cut of just over 20 per cent. …
Latest Video
New Stories
-
New report highlights growing gene and cell therapy industry
January 24, 2020 - - Latest News -
Australian access behind comparable countries?
January 24, 2020 - - Latest News -
CSL Behring welcomes new presentations for genetic condition
January 24, 2020 - - Latest News -
Couple call on Jacinda Ardern to act on PHARMAC
January 24, 2020 - - Latest News -
Transparency of process is more important than transparency of outcome
January 23, 2020 - - Latest News -
CSL makes US-list of Best Employers for Diversity
January 23, 2020 - - Latest News -
AbbVie welcomes RINVOQ approval
January 23, 2020 - - Latest News